Cold Turkey: What the Success Rate Actually Is

Most quit attempts are unassisted. Depending on the survey, 55-75% of smokers who try to quit in a given year do so without NRT, medication or formal behavioral support. The result: roughly 3-5% of those attempts produce sustained abstinence at six months or longer [1]. This is not an argument against quitting. It is an argument for using the tools that improve the odds.

What the numbers actually say

The per-attempt success rate for unassisted quitting is consistently low in population data. A review of the natural history of quit attempts found that roughly 3-5% of unassisted attempts produce sustained abstinence at 6-12 months [1]. That figure comes from population surveys and observational studies tracking large groups of smokers over time, and it has been replicated across multiple countries and time periods.

Clinical trial placebo arms, which include some behavioral support (regular check-ins, encouragement, a quit date), show somewhat higher rates of about 8-10%. This is not a contradiction; it reflects the fact that even minimal behavioral support, having someone check in on your progress, improves outcomes compared to a completely unassisted attempt.

These numbers compare to:

Method	Six-month quit rate	Comparison	Evidence base
Cold turkey (population)	~3-5%	No support	Observational data
Placebo with support	~8-10%	Behavioral support only	Clinical trials
Single NRT	~15-20%	~2x placebo	136 Cochrane trials
Combination NRT	~15-25% above single NRT	Patch + gum/lozenge	Multiple trials
Varenicline	~25-30%	~3x placebo	39 Cochrane trials

The relative benefit of pharmacological support is one of the most replicated findings in cessation research. It appears across populations, countries and study designs [2] [3]. The doubling effect of NRT and the tripling effect of varenicline are consistent enough that Cochrane reviews based on tens of thousands of participants confirm them with narrow confidence intervals.

What the relapse curve looks like

The pattern of relapse after an unassisted quit attempt follows a characteristic curve. Most relapses occur in the first two weeks, when nicotine withdrawal symptoms are at their peak. Of people who relapse, approximately half do so within the first week. By the end of the first month, the relapse rate has slowed substantially, and by three months, those who remain abstinent have a high probability of maintaining it through six months and beyond [1].

This curve has a practical implication: the first two weeks are the critical window. Pharmacological support, NRT or prescription medication, works primarily by making this window survivable. It does not eliminate cravings; it lowers their intensity enough that the person can get through the peak period without smoking. The relapse curve for pharmacologically assisted attempts has the same general shape but starts from a higher retention rate at each time point.

The difference between the assisted and unassisted curves is not subtle. At two weeks, an unassisted attempt retains roughly 25-30% of quitters. An NRT-assisted attempt retains roughly 40-50%. A varenicline-assisted attempt retains roughly 50-60%. These are approximate figures drawn from trial data, not precise point estimates, but the relative ordering is consistent.

The paradox in the population data

A finding that initially seems contradictory: most long-term ex-smokers report having quit without pharmacological help [4]. This is true, and it is frequently cited in defense of cold turkey. But it does not mean cold turkey is the better strategy. The explanation is arithmetic.

More people attempt cold turkey than assisted quitting. Even at a lower per-attempt success rate, the larger number of attempts produces a larger absolute number of successes. If 75% of quit attempts are unassisted and 25% are assisted, the unassisted pool generates more total quitters simply because it is larger, even though each individual attempt is less likely to succeed. If 100 people try cold turkey and 5 succeed, and 30 people try NRT and 6 succeed, the cold turkey group has more quitters (5 vs. 6 is close) despite a much lower success rate (5% vs. 20%).

The question for any individual smoker is not “which method has produced more ex-smokers in the population” but “which method gives me the best odds on this attempt.” The answer to the second question is consistently and clearly: assisted quitting.

There is also a survivorship bias in retrospective surveys: the ex-smokers who report quitting cold turkey are the ones for whom it worked. The much larger group for whom it did not work either eventually quit using assistance or are still smoking. The successful cold-turkey quitters are visible; the failed cold-turkey quitters are invisible in retrospective data.

Why people choose cold turkey

The willpower narrative. Quitting smoking is culturally framed as a test of willpower. Using NRT or medication is sometimes perceived as a crutch, as evidence of insufficient commitment, or as somehow less impressive than quitting unaided. This framing has no basis in cessation science. Nicotine dependence is a neurochemical condition involving specific receptor adaptations in the brain, and pharmacological support addresses the neurochemical component. Framing cessation as a character test is roughly equivalent to framing diabetes management as a matter of resolve.

Cost. NRT and prescription medications cost money. For smokers without insurance coverage for cessation, which varies substantially by state and plan, the upfront cost of NRT can be a real barrier. A two-week supply of nicotine patches costs roughly $30-50, and a full 8-12 week course costs more. This is a meaningful expense for many people, even though the cost of continued smoking (roughly $7-10 per pack, daily) exceeds the cost of NRT over any timeframe longer than a few weeks. Prescription medications like varenicline may cost more without insurance, though many insurance plans cover cessation treatments when prescribed.

Lack of awareness. Some smokers are not aware that nicotine patches, gum and lozenges are available over the counter without a prescription. They are not aware that combination NRT, using a patch plus a short-acting form, is recommended by clinical guidelines and outperforms single NRT. They are not aware that the Quitline (1-800-QUIT-NOW) can provide free NRT in many states, or that many state Medicaid programs cover cessation treatment.

Concern about NRT dependence. The idea that NRT is “trading one addiction for another” is common and understandable. It misunderstands the purpose: NRT provides nicotine without the roughly 7,000 chemicals in cigarette smoke, including dozens of known carcinogens. NRT dependence does occur in a small percentage of long-term users, particularly with gum, but long-term NRT use is vastly less harmful than continued smoking. The appropriate comparison is not NRT dependence vs. no dependence; it is NRT dependence vs. the dependence the person already has on cigarettes.

How many attempts does it take

The commonly cited figure of 8-11 attempts is based on survey data with varying definitions of what counts as a “quit attempt.” A Canadian longitudinal study using a broad definition, including brief attempts of less than 24 hours, suggested the number may be 30 or more [5]. The precise number is less important than the principle: most smokers make multiple attempts before achieving sustained abstinence, and each attempt with better tools improves the odds.

This is not discouraging information. It means that a failed attempt is a normal part of the quitting process, not a terminal outcome. It also means that upgrading the method on the next attempt, from cold turkey to NRT, from single NRT to combination NRT, from NRT to varenicline, is the single most practical thing a person can do to improve their odds.

What this means if you’re deciding

If you have tried cold turkey and it did not work, that is not a failure of willpower. It is the expected outcome for roughly 95% of unassisted attempts. The next step is not to try harder; it is to try with pharmacological support.

The practical hierarchy based on the evidence: combination NRT (patch plus gum or lozenge) is available without a prescription and roughly doubles quit rates compared to cold turkey. Varenicline roughly triples them but requires a prescription and a clinician conversation. Adding behavioral support, through the Quitline, a group program or clinician counseling, improves outcomes on top of any pharmacological method.

If cold turkey has worked for you in the past and you relapsed months or years later, the relapse was likely driven by a situational trigger rather than acute withdrawal. For the next attempt, the pharmacological support addresses the acute phase, but planning for the behavioral triggers is what protects the long-term outcome.

For smokers with COPD, the stakes of repeated failed attempts are high because lung function continues declining with each year of continued smoking. The decline is accelerated compared to non-smokers with COPD, and the damage from each additional year is not recoverable. Using the highest-efficacy available method from the first attempt is the most protective approach. In this population, the argument for starting with combination NRT or varenicline rather than cold turkey is not just statistical; it is clinical.

What cold turkey does well

This is not a dismissal of cold turkey. It works for some people, and the people for whom it works tend to share certain characteristics: lighter smoking histories (fewer than 10 cigarettes per day), fewer previous failed attempts, strong situational motivation (a health scare, a pregnancy, a specific life event) and lower levels of measured nicotine dependence. For this subgroup, cold turkey may be the right approach, and nothing in the evidence says they should use pharmacological support if they do not need it.

The evidence says that for the average smoker, and particularly for heavy smokers and those with previous failed attempts, pharmacological support substantially improves the odds. The site does not have a preferred method. The trials do.

A doctor or pharmacist can help choose the right approach for your health history. The Quitline (1-800-QUIT-NOW) provides free coaching and can sometimes supply NRT.